Related Experiment Video
Updated: Feb 11, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.3K
Nerve Growth Factor: Early Studies and Recent Clinical Trials
Maria Luisa Rocco1,2, Marzia Soligo1, Luigi Manni1
1Institute of Translational Pharmacology, CNR, Rome, Italy.
Current Neuropharmacology
|April 14, 2018
Summary
Nerve growth factor (NGF) is crucial for nerve cell health and has shown therapeutic potential for various conditions, including ulcers and eye diseases. This review highlights clinical studies on NGF
Area of Science:
- Neurobiology
- Neurotrophic Factors
- Regenerative Medicine
Background:
- Nerve growth factor (NGF) is a key regulator of neuronal survival, growth, and differentiation in both developing and adult nervous systems.
- NGF is the founding member of the neurotrophin family, which includes BDNF, NT-3, and NT-4/5.
- Initial discovery focused on NGF's role in peripheral neuron survival and differentiation.
Purpose of the Study:
- To review clinical studies investigating the therapeutic applications of purified nerve growth factor (NGF).
- To present findings from previous, recent, and ongoing research on NGF's efficacy.
- To explore NGF's potential in treating various neurological and ocular conditions.
Main Methods:
- Review of clinical studies focusing on topical administration of purified NGF.
- Analysis of research data from human trials and patient cases.
- Compilation of findings from ongoing and past research initiatives.
Main Results:
- NGF demonstrates significant therapeutic potential when administered topically.
- Clinical studies indicate efficacy in treating human cutaneous pressure ulcers and corneal ulcers.
- Promising results observed in glaucoma, retinal maculopathy, Retinitis Pigmentosa, pediatric optic gliomas, and brain traumas.
Conclusions:
- Nerve growth factor (NGF) possesses notable therapeutic properties for a range of conditions.
- Topical NGF administration shows promise for treating ocular diseases and neurological injuries.
- Further clinical investigation supports NGF's role in regenerative medicine and neuroprotection.
Related Concept Videos
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview
5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Statistical Software for Data Analysis and Clinical Trials
1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Role of Hematopoietic Growth Factors
4.0K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.0K
Factors Influencing Microbial Growth: pH
1.3K
Microorganisms are classified as acidophiles, neutrophiles, or alkaliphiles based on their pH growth preferences, reflecting their adaptations to specific environments. Maintaining a stable intracellular pH is critical for macromolecular stability and enzymatic activity, which can be challenged by external pH variations.Neutrophiles, such as Escherichia coli, grow optimally between pH 5.5 and 8.0. These microorganisms inhabit neutral or slightly acidic environments and employ mechanisms like...
1.3K
Factors Influencing Microbial Growth: Temperature
1.4K
Microorganisms display remarkable adaptations, enabling them to thrive in diverse ecological niches across a wide range of temperatures. Temperature profoundly influences microbial growth by affecting enzymatic activity, membrane fluidity, and other cellular processes.Each microorganism operates within a specific temperature range defined by three cardinal points: minimum, optimum, and maximum. Below the minimum temperature, membranes lose fluidity, halting transport processes. Above the...
1.4K

